3330-0998 Screening compound: 4-(morpholine-4-sulfonyl)-N-{4'-[4-(morpholine-4-sulfonyl)benzamido]-[1,1'-biphenyl]-4-yl}benzamide

3330-0998 Screening compound: 4-(morpholine-4-sulfonyl)-N-{4'-[4-(morpholine-4-sulfonyl)benzamido]-[1,1'-biphenyl]-4-yl}benzamide
3330-0998 Screening compound: 4-(morpholine-4-sulfonyl)-N-{4'-[4-(morpholine-4-sulfonyl)benzamido]-[1,1'-biphenyl]-4-yl}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 3330-0998
4-(morpholine-4-sulfonyl)-N-{4'-[4-(morpholine-4-sulfonyl)benzamido]-[1,1'-biphenyl]-4-yl}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3330-0998

Molecular Formula

C34H34N4O8S2 (C34 H34 N4 O8 S2)

Compound Name

4-(morpholine-4-sulfonyl)-N-{4'-[4-(morpholine-4-sulfonyl)benzamido]-[1,1'-biphenyl]-4-yl}benzamide

IUPAC name

4-(morpholine-4-sulfonyl)-N-{4'-[4-(morpholine-4-sulfonyl)benzamido]-[11'-biphenyl]-4-yl}benzamide

SMILES

O=C(c(cc1)ccc1S(N1CCOCC1)(=O)=O)Nc(cc1)ccc1-c(cc1)ccc1NC(c(cc1)ccc1S(N1CCOCC1)(=O)=O)=O

InChI

InChI=1S/C34H34N4O8S2/c39-33(27-5-13-31(14-6-27)47(41,42)37-17-21-45-22-18-37)35-29-9-1-25(2-10-29)26-3-11-30(12-4-26)36-34(40)28-7-15-32(16-8-28)48(43,44)38-19-23-46-24-20-38/h1-16H,17-24H2,(H,35,39)(H,36,40)

InChI Key

SUNOHCGPUFIPOH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD02927001

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

690.8

Hydrogen Bond Acceptors Count

16.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

12

Partition Coefficient, logP

3.891

Distribution Coefficient, logD

3.891

Water Solubility, LogSw

-4.23

Polar Surface Area

125.388

Acid Dissociation Constant (pKa)

10.90

Base Dissociation Constant (pKb)

-2.67

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.50

3330-0998 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with 3330-0998 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 3330-0998?
Check Price and Availability of 3330-0998, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 3330-0998 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 3330-0998
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 3330-0998
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 3330-0998 available by request